Lessons Learned from the PROTECTED TAVR Trial: Mapping the Future of Cerebral Embolic Protection
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Equity/Stock(s)/Options - Navigate
- Advisory Board - Admedus